200 related articles for article (PubMed ID: 21407214)
1. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.
Abnet CC; Zheng W; Ye W; Kamangar F; Ji BT; Persson C; Yang G; Li HL; Rothman N; Shu XO; Gao YT; Chow WH
Br J Cancer; 2011 Apr; 104(9):1511-6. PubMed ID: 21407214
[TBL] [Abstract][Full Text] [Related]
2. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
[TBL] [Abstract][Full Text] [Related]
4. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
[TBL] [Abstract][Full Text] [Related]
5. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
8. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
9. Serum pepsinogen II is a better diagnostic marker in gastric cancer.
Cao XY; Jia ZF; Jin MS; Cao DH; Kong F; Suo J; Jiang J
World J Gastroenterol; 2012 Dec; 18(48):7357-61. PubMed ID: 23326145
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
[TBL] [Abstract][Full Text] [Related]
13. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of
Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
[TBL] [Abstract][Full Text] [Related]
15. ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis.
Shimoyama T; Aoki M; Sasaki Y; Matsuzaka M; Nakaji S; Fukuda S
Gastric Cancer; 2012 Jul; 15(3):331-4. PubMed ID: 22282137
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
[TBL] [Abstract][Full Text] [Related]
18. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N
Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]